Company news

Agenus Inc. news in 2022

Agenus Inc.'s news releases, calls and decks from 2022, newest first.

View company

Agenus Provides Corporate Update and Third Quarter 2022 Financial Report

November 7, 2022

Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report

October 24, 2022

Agenus Makes Senior Regulatory and Clinical Appointments

September 11, 2022

Agenus Initiates Botensilimab Phase 2 ACTIVATE Trials in Advanced MSS Colorectal Cancer and Advanced Melanoma

September 11, 2022

Agenus Provides Corporate Update and Second Quarter 2022 Financial Report

August 8, 2022

Agenus Announces First Patient Dosed in Phase 1 Study of AGEN1571 (anti-ILT2) in Advanced Solid Tumors

July 31, 2022

Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report

July 26, 2022

Agenus Advances Portfolio with 6 Clinical Collaborations

May 30, 2022

Agenus Announces Late-Breaking Oral Presentation at ESMO-GI and Strategies to Advance Botensilimab

May 23, 2022

Agenus Corporate Update and First Quarter 2022 Financial Report

May 9, 2022

Agenus to Provide Corporate Update and First Quarter 2022 Financial Report

April 25, 2022

Agenus Presents Data on AGEN1571 (anti-ILT2) at AACR and Announces IND Clearance

April 7, 2022

Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report

February 28, 2022

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report

February 14, 2022

Calls in 2022

Decks in 2022